التفاصيل البيبلوغرافية
| العنوان: |
Life-threatening anaemia in patient with hereditary haemorrhagic telangiectasia (RenduOsler-Weber syndrome). |
| المؤلفون: |
Mikołajczyk-Solińska, Melania, Leończyk, Karolina, Brzezina, Aleksandra, Rossa, Sylwia, Kasznicki, Jacek |
| المصدر: |
Open Medicine; Jan2020, Vol. 15 Issue 1, p134-138, 5p, 1 Color Photograph, 1 Black and White Photograph |
| مستخلص: |
Hereditary haemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber syndrome, is a rare autosomal dominant vascular disorder. Patients with HHT may present with a wide spectrum of clinical manifestations from epistaxis to clinically significant arteriovenous malformations (AVM) in the lungs, liver, brain and spine. The diagnosis of HHT is based on clinical criteria. There is a long diagnostic delay of nearly 3 decades since disease onset. The treatment is based on various types of haemostasis. There is ongoing research with potential therapies which may prevent and decrease the severity of epistaxis. Thalidomide may be an effective treatment to decrease the bleeding symptoms of patients with HHT. [ABSTRACT FROM AUTHOR] |
|
Copyright of Open Medicine is the property of De Gruyter and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder